查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679428

美国乳房重建市场规模、份额、趋势分析报告：按产品、类型、最终用途和细分市场预测，2025-2030 年

U.S. Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander, Acellular Dermal Matrix), By Shape (Round, Anatomical), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国乳房重建市场的成长和趋势

根据 Grand View Research, Inc. 的新报告，美国乳房重建市场预计到 2030 年将达到 16.5 亿美元，2025 年至 2030 年的复合年增长率为 6.8%。

由于寻求重组的乳癌倖存者数量不断增加、人们对乳癌治疗的认识不断提高以及手术技术的进步，市场正在经历强劲增长。此外，重组手术的保险覆盖范围的扩大和微创技术的采用率的提高也促进了市场的成长。随着越来越多的女性接受切除术并寻求恢復乳房外观的方法，对这些手术的需求只会增加。

美国乳房重建市场的新产品发布和 FDA核准透过刺激创新、提高安全标准和改善临床结果推动了乳房重建的重要进步。 2023 年 10 月，Establishment Labs 推出了 Motiva Flora SmoothSilk 组织扩张器，这是美国首个获得 FDA 批准的产品。这使得 MRI 扫描能够不受阻碍地进行，这对于术后监测和癌症筛检至关重要。 Establishment Labs 的这项创新有可能简化需要 MRI 扫描的患者的乳房重建过程。

随着患者越来越青睐这项技术，美国乳房重建市场正向组织扩张器发生重大转变。组织扩张器，也称为组织扩张器系统，是一种可植入装置，用于拉伸和扩张皮肤和软组织，为乳房重建手术做准备。该技术因其能够提供更自然的外观和感觉，并减少恢復时间和疤痕而广受欢迎。乳房切除术后，使用组织扩张器来扩大乳房袋，以便放置乳房植入。两阶段扩张器至植入乳房重建占美国乳房重建手术的一半以上。在过去的几十年里，组织扩张技术取得了显着的进展。

美国乳房重建市场报告重点

  • 根据产品来看，与组织瓣等其他选择相比，植入由于外观自然、恢復时间更短、风险更低，占据了市场主导地位，拥有最大的收入份额。
  • 根据形态，圆形部分占据了最大的销售份额，因为它提供了许多患者喜欢的更饱满、更对称的外观。
  • 根据最终用途，医院占收入的最大份额。该医院进行最多的乳房切除术和重组手术。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国乳房重建市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国乳房重建市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章美国乳房重建市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 美国乳房重建市场的产品趋势分析
  • 2018-2030年美国乳房重建市场规模及产品趋势分析
  • 植入
    • 硅胶乳房植入
    • 生理食盐水乳房植入
  • 组织扩张器
    • 生理食盐水扩张器
    • 空气组织扩张器
  • 去细胞真皮基质

第五章美国乳房重建市场：按类型、估计和趋势分析

  • 细分仪表板
  • 美国乳房重建市场的波动
  • 2018-2030年美国乳房重建市场规模及趋势分析（按类型）
  • 圆形的
  • 解剖学

第六章美国乳房重建市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 美国乳房重建市场的最终用途趋势分析
  • 2018-2030年美国乳房重建市场规模及趋势分析（依最终用途）
  • 医院
  • 美容诊所
  • 门诊手术中心

第七章竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • Mentor Medical Systems（Johnson & Johnson）
    • Allergan, Inc.（AbbVie）
    • Sientra, Inc.（Acquired by Tiger Aesthetics Medical, LLC）
    • Ideal Implant, Inc.（Bimini Health Tech.）
    • Establishment Labs
    • RTI Surgical
    • Integra LifeSciences Corporation
Product Code: GVR-4-68040-523-4

U.S. Breast Reconstruction Market Growth & Trends:

The U.S. breast reconstruction market size is anticipated to reach USD 1.65 billion by 2030 and is projected to expand at a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to the increasing number of breast cancer survivors seeking reconstruction, growing awareness about breast cancer treatments, and advancements in surgical techniques. In addition, the availability of insurance coverage for reconstruction procedures and the increasing adoption of minimally invasive methods contribute to market growth. As more women undergo mastectomies and look for options to restore breast appearance, the demand for these procedures continues to rise.

New product launches and FDA approvals in the U.S. breast reconstruction market drive significant breast reconstruction advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In October 2023, Establishment Labs announced the FDA clearance of their Motiva Flora SmoothSilk Tissue Expander, the first of its kind to receive FDA clearance in the U.S. The Motiva Flora expander eliminates the use of magnets in the filling port, making it MRI-conditional. It allows unimpeded MRI scans, crucial for post-surgical monitoring and cancer screening. This innovation by Establishment Labs has the potential to streamline the breast reconstruction process for patients who require MRI scans.

The U.S. breast reconstruction market is witnessing a significant shift toward tissue expanders as patients increasingly prefer this technology. Tissue expanders, also known as tissue expander systems, are implantable devices used to stretch and expand the skin & soft tissues in preparation for breast reconstruction surgery. This technology has gained popularity due to its ability to provide a more natural look and feel, as well as reduced recovery time & scarring. Tissue expanders are used to extend the breast pocket following a mastectomy so that a breast implant can be placed. Two-stage expander-to-implant breast reconstruction accounts for more than half of all breast reconstruction surgeries in the U.S. In the last few decades, tissue expansion technology has significantly advanced.

U.S. Breast Reconstruction Market Report Highlights:

  • Based on product, the implants segment dominates the market with the largest revenue share owing to their ability to provide natural-looking results, shorter recovery times, and lower risk compared to other options like tissue flaps.
  • Based on shape, the round segment dominate the market with the largest revenue share because they offer a fuller, more symmetrical appearance, which many patients prefer.
  • Based on end use, the hospitals dominated the market with the largest revenue share. Hospitals perform the highest number of mastectomy and reconstruction surgeries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Reconstruction Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing awareness and acceptability of breast reconstruction among women with breast cancer
      • 3.2.1.2. Increasing number of breast reconstructive procedures
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Complications associated with implants and product recalls
  • 3.3. U.S. Breast Reconstruction Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Reconstruction Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Reconstruction Market Product Movement Analysis
  • 4.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Implants
    • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Silicone Breasts Implants
      • 4.4.2.1. Silicone Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Saline Breasts Implants
      • 4.4.3.1. Saline Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Tissue Expander
    • 4.5.1. Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Saline Expander
      • 4.5.2.1. Saline Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Air Tissue Expander
      • 4.5.3.1. Air Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Acellular Dermal Matrix
    • 4.6.1. Acellular Dermal Matrix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Breast Reconstruction Market: Shape Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Reconstruction Market Shape Movement Analysis
  • 5.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Shape, 2018 to 2030 (USD Million)
  • 5.4. Round
    • 5.4.1. Round Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Anatomical
    • 5.5.1. Anatomical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Breast Reconstruction Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Reconstruction Market End Use Movement Analysis
  • 6.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cosmetology Clinics
    • 6.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Mentor Medical Systems (Johnson & Johnson)
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Performance
      • 7.2.1.3. Service Benchmarking
      • 7.2.1.4. Strategic Initiatives
    • 7.2.2. Allergan, Inc. (AbbVie)
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Performance
      • 7.2.2.3. Service Benchmarking
      • 7.2.2.4. Strategic Initiatives
    • 7.2.3. Sientra, Inc. (Acquired by Tiger Aesthetics Medical, LLC)
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Financial Performance
      • 7.2.3.3. Service Benchmarking
      • 7.2.3.4. Strategic Initiatives
    • 7.2.4. Ideal Implant, Inc. (Bimini Health Tech.)
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Financial Performance
      • 7.2.4.3. Service Benchmarking
      • 7.2.4.4. Strategic Initiatives
    • 7.2.5. Establishment Labs
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Financial Performance
      • 7.2.5.3. Service Benchmarking
      • 7.2.5.4. Strategic Initiatives
    • 7.2.6. RTI Surgical
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Financial Performance
      • 7.2.6.3. Service Benchmarking
      • 7.2.6.4. Strategic Initiatives
    • 7.2.7. Integra LifeSciences Corporation
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Financial Performance
      • 7.2.7.3. Service Benchmarking
      • 7.2.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S Breast Reconstruction Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 U.S Breast Reconstruction Market, By Shape, 2018 - 2030 (USD Million)
  • Table 5 U.S Breast Reconstruction Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6 Participant's Overview
  • Table 7 Financial Performance
  • Table 8 Product Benchmarking
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Breast Reconstruction Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Breast Reconstruction Market, for Implants, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Breast Reconstruction Market, for Silicone Breasts Implants, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Breast Reconstruction Market, for Saline Breasts Implants, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Breast Reconstruction Market, for Tissue Expander, 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Breast Reconstruction Market, for Saline Expander, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Breast Reconstruction Market, for Air Tissue Expander, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Breast Reconstruction Market, for Acellular Dermal Matrix, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Breast Reconstruction Market, for Round, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Breast Reconstruction Market, for Anatomical, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Breast Reconstruction Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Breast Reconstruction Market, for Cosmetology Clinics, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Breast Reconstruction Market, for Ambulatory Surgical Centers, 2018 - 2030 (USD Million)